William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Albireo Announces Proposed Public Offering of Common Stock
-
William Blair Reiterates Market Perform on 8x8, Inc. (EGHT) Ahead of 3Q Release
-
Rapid7, Inc. (RPD) to Offer 5.18M Shares of Common Stock, Provides FY18 Outlook
-
Rapid7 Announces Proposed Public Offering of Common Stock, Preliminary Financial Results and 2018 Outlook
-
Rapid7 Announces Proposed Public Offering of Common Stock, Preliminary Financial Results and 2018 Outlook
-
Pre-Open Movers 01/23: (RGSE) (CNET) (NFLX) Higher; (GPRO) (ADMS) (TWTR) Lower (more...)
-
William Blair Downgrades Nordstrom (JWN) to Market Perform
-
William Blair Starts Global Blood Therapeutics (GBT) at Outperform; Says 30-50% Upside Remains, Including Potential Takeout
-
Form D/A William Blair Systematic
-
BeiGene Announces Closing of $800 Million Public Offering
-
William Blair Upgrades Dunkin' Brands (DNKN) to Outperform
-
Pre-Open Movers 01/19: (FORD) (ACOR) (EMAN) Higher; (GNC) (TEAM) (IBM) Lower (more...)
-
Form D/A William Blair Global
-
William Blair Downgrades Appian Corp. (APPN) to Market Perform
-
BeiGene (BGNE) Prices 7.426M ADS Offering at $101/Sh
-
BeiGene Announces Pricing of $750 Million Public Offering
-
'Flawed' Taiwan Study Causes Drop in Shares of Exact Sciences (EXAS)
-
Exact Sciences (EXAS) Defended at William Blair
-
PlacementTracker Publishes 2017 PIPE and Private Placement Markets League Tables
-
William Blair Starts Pieris Pharmaceuticals (PIRS) at Outperform
-
William Blair Downgrades Willis Towers Watson (WLTW) to Market Perform, 'London Broker Compensation Study Creates an Overhang'
-
William Blair Downgrades Aon Corp (AON) to Market Perform, 'London Broker Compensation Study Creates an Overhang'
-
William Blair Downgrades SS&C Technologies Holdings, Inc. (SSNC) to Market Perform
-
William Blair Starts Cambrex Corporation (CBM) at Outperform, 'Small Molecule API Specialist Looks to Capitalize on Outsourcing Trend'
-
CURO Announces Exercise of Underwriter Option to Initial Public Offering
-
Victory Capital Files Registration Statement for Proposed Initial Public Offering
-
William Blair Remains Sidelined on Workday (WDAY) Following SAP Announcement
-
Drew Thomas Joins Webroot as Vice President of Corporate Development
-
William Blair Reiterates Market Perform Rating on Valmont Industries (VMI) Following 'Model Update for Estimated Impact of Tax Plan'
-
William Blair Starts Casa Sytems, Inc. (CASA) at Outperform, 'Cable Broadband Leader Broadening Its Horizons'
-
William Blair Downgrades Natus Medical (BABY) to Market Perform
-
William Blair Downgrades Illumina (ILMN) to Market Perform 'Based on Where We Are at in New Product Cycle Adoption Curve'
-
ATARA Biotherapeutics (ATRA) Prices 7M Share Common Offering at $18.25/Sh
-
Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
-
Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
-
William Blair Starts Core-Mark Holding (CORE) at Outperform
-
Trintech Announces Growth Equity Investment from Summit Partners
-
William Blair Upgrades Titan Machinery (TITN) to Market Perform, 'Worst Behind and Steady Improvements Should Be Coming'
-
William Blair Upgrades Astec Industries (ASTE) to Outperform
-
William Blair Starts CURO Group (CURO) at Outperform
-
Form 40-17G WILLIAM BLAIR FUNDS
-
Acer Therapeutics Announces Partial Exercise of Over-allotment Option in Public Offering
-
Avaya (AVYA) Re-Emerges from Chapter 11; Seeks to List on NYSE by End of January - William Blair
-
William Blair Reiterates Outperform on Everbridge, Inc. (EVBG) Following Vermont Contract Win
-
William Blair Downgrades Agile Therapeutics (AGRX) to Market Perform
-
Chipotle Mexican Grill (CMG) Estimates Lowered at William Blair on Calif. Outbreak
-
Attunity Ltd. Announces Closing of Option Relating to Public Offering of Ordinary Shares
-
William Blair Assumes Cardiovascular Systems (CSII) at Market Perform
-
Alteryx (AYX) Defended at William Blair After Accidental Data Exposure
-
William Blair Downgrades Genomic Health Inc. (GHDX) to Market Perform

